LinaTech Showcases Cutting-Edge Radiotherapy Solutions at the Arab Health Exhibition

Jan 24, 2011

LinaTech attended the Arab Health Exhibition from January 23-27, 2011 at the Dubai World Trade Centre in the UAE. This annual event brings together healthcare professionals and industry experts from around the world to showcase the latest advancements in medical technology.

Our new type of Dynamic Multi-leaf Collimator (DMLC H) is being shown on the exhibition, and it attracts the customers from all over the world.

At the exhibition, LinaTech showcased their latest innovation, the Dynamic Multi-leaf Collimator H (DMLC H). This new type of DMLC drew the attention of customers from all over the world due to its advanced capabilities in delivering precise and efficient radiotherapy treatments.

The DMLC H is designed to improve the accuracy of radiation dose delivery, resulting in better treatment outcomes for cancer patients. With 160 individual leaves, the DMLC H is capable of shaping radiation beams to conform to the shape of the tumor, while minimizing the dose to surrounding healthy tissues. The DMLC H also offers fast and efficient treatment delivery, reducing the time that patients need to spend on the treatment table.

LinaTech's participation in the Arab Health Exhibition provided an opportunity for healthcare professionals to learn more about the benefits of using the DMLC H and other advanced radiotherapy solutions in the fight against cancer. By showcasing their innovative technology, LinaTech continues to demonstrate its commitment to advancing the field of radiation therapy and improving cancer treatment outcomes for patients around the world.

In addition to showcasing their technology, LinaTech also used the Arab Health Exhibition as an opportunity to network and establish partnerships with healthcare professionals and industry experts from around the globe. Through these partnerships, LinaTech is better equipped to meet the needs of healthcare providers and patients worldwide


To learn more, please contact us.